Alakhova DY - Search Results

1

Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors.

Hu H, Petrosyan A, Osna NA, Liu T, Olou AA, Alakhova DY, Singh PK, Kabanov AV, Faber EA Jr, Bronich TK. Hu H, et al. Among authors: alakhova dy. J Control Release. 2019 Jul 28;306:149-164. doi: 10.1016/j.jconrel.2019.05.026. Epub 2019 May 20. J Control Release. 2019. PMID: 31121280 Free PMC article.

2

Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.

Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV. Alakhova DY, et al. J Control Release. 2010 Feb 25;142(1):89-100. doi: 10.1016/j.jconrel.2009.09.026. Epub 2009 Oct 6. J Control Release. 2010. PMID: 19815037 Free PMC article.

3

A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV. Zhao Y, et al. Among authors: alakhova dy. J Control Release. 2013 May 28;168(1):61-9. doi: 10.1016/j.jconrel.2013.02.026. Epub 2013 Mar 6. J Control Release. 2013. PMID: 23474033 Free PMC article.

4

Nanomedicine and nanotechnology are rapidly developing fields across the nation and worldwide.

Alakhova DY, Kabanov AV. Alakhova DY, et al. J Control Release. 2015 Jun 28;208:1. doi: 10.1016/j.jconrel.2015.04.044. J Control Release. 2015. PMID: 25965907 No abstract available.

5

Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles.

Luxenhofer R, Sahay G, Schulz A, Alakhova D, Bronich TK, Jordan R, Kabanov AV. Luxenhofer R, et al. J Control Release. 2011 Jul 15;153(1):73-82. doi: 10.1016/j.jconrel.2011.04.010. Epub 2011 Apr 13. J Control Release. 2011. PMID: 21513750 Free PMC article.

6

Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Mahajan V, Gaymalov Z, Alakhova D, Gupta R, Zucker IH, Kabanov AV. Mahajan V, et al. Biomaterials. 2016 Jan;75:58-70. doi: 10.1016/j.biomaterials.2015.10.002. Epub 2015 Oct 9. Biomaterials. 2016. PMID: 26480472 Free PMC article.

7

Endocytosis of nanomedicines.

Sahay G, Alakhova DY, Kabanov AV. Sahay G, et al. Among authors: alakhova dy. J Control Release. 2010 Aug 3;145(3):182-95. doi: 10.1016/j.jconrel.2010.01.036. Epub 2010 Mar 10. J Control Release. 2010. PMID: 20226220 Free PMC article. Review.

8

Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia.

Alakhova DY, Zhao Y, Li S, Kabanov AV. Alakhova DY, et al. PLoS One. 2013 Aug 19;8(8):e72238. doi: 10.1371/journal.pone.0072238. eCollection 2013. PLoS One. 2013. PMID: 23977261 Free PMC article.

9

Can nanomedicines kill cancer stem cells?

Zhao Y, Alakhova DY, Kabanov AV. Zhao Y, et al. Among authors: alakhova dy. Adv Drug Deliv Rev. 2013 Nov;65(13-14):1763-83. doi: 10.1016/j.addr.2013.09.016. Epub 2013 Oct 10. Adv Drug Deliv Rev. 2013. PMID: 24120657 Free PMC article. Review.

10

Pluronics and MDR reversal: an update.

Alakhova DY, Kabanov AV. Alakhova DY, et al. Mol Pharm. 2014 Aug 4;11(8):2566-78. doi: 10.1021/mp500298q. Epub 2014 Jul 10. Mol Pharm. 2014. PMID: 24950236 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters